8
Oct
2024

Inke S.A.

Exhibitor at CPHI Milan 2024 stand 3A105, API
About Us

Inke S.A., a wholly owned subsidiary of Neuraxpharm, is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes, mainly for use in inhalation therapies and CNS.

Based in Barcelona (Spain) and counting more than twenty years’ experience in micronisation, Inke is in continuous international expansion since 1998, delivering APIs all over the world, including US, Europe and Japan.
 

OUR QUALITY

...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • ES
  • 2017
    On CPHI since
  • 50 - 99
    Employees
Company types
Other
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 3A105, API

Products Featured at CPHI Milan 2024

  • Aclidinium bromide

    Product Aclidinium bromide

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aclidinium. Indication: COPD treatment
  • Aprepitant

    Product Aprepitant

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Aprepitant. Indication: Emesis

  • Arformoterol tartrate polymorph A and D

    Product Arformoterol tartrate polymorph A and D

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Arformoterol tartrate. Indication for COPD 

    US and CN DMF available
  • Asenapine maleate

    Product Asenapine maleate

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Asenapine. Indications: Schizophrenia and acute mania

  • Carvedilol

    Product Carvedilol

    Inke (API manufacturer) part of Neuraxpharm, provides wide range of APIs which includes Carvedilol. Indications: hypertension, angina and heart failure


    JP DMF available